Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stingray Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Stingray Therapeutics

Stingray Therapeutics

Series A

Stingray Therapeutics: A Houston-based biotech firm innovating cancer immunotherapies since 2018.

HQ
Houston, TX, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Stingray Therapeutics is a biotech company based in Houston, Texas, founded in 2018. The company focuses on developing next-generation immunotherapies to treat various types of cancer. Their core mission is to enable the full immune system to combat cancer effectively. Stingray Therapeutics aims to bring innovative cancer treatments to the market, leveraging cutting-edge research and technology to improve patient outcomes.

Under the leadership of CEO Jon Northrup, Stingray Therapeutics has made significant strides in the field of cancer immunotherapy. The company has received multiple grants and awards, highlighting its revolutionary approach and potential impact on cancer treatment. Stingray Therapeutics continues to advance its clinical-stage therapies, contributing to the broader effort of enhancing cancer care and patient survival rates.

Stingray Therapeutics - Similar Companies

Palm Therapeutics logo

Palm Therapeutics

LTZ Therapeutics logo

LTZ Therapeutics

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

Seneca Therapeutics logo

Seneca Therapeutics

Stellanova Therapeutics logo

Stellanova Therapeutics

stellanovatx.com

Starton Therapeutics logo

Starton Therapeutics

Elstar Therapeutics logo

Elstar Therapeutics

Tizona Therapeutics logo

Tizona Therapeutics

tizonatx.com

Mongoose Bio logo

Mongoose Bio

mongoosebio.com

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Oncosting logo

Oncosting

oncosting.com

Pelican Therapeutics logo

Pelican Therapeutics

Imvaq Therapeutics logo

Imvaq Therapeutics

Immunome logo

Immunome

Thunder Biotech logo

Thunder Biotech

thunderbiotech.com

Stingray Therapeutics - Quick Facts

Who are Stingray Therapeutics' competitors?

Companies similar to Stingray Therapeutics include Palm Therapeutics, LTZ Therapeutics, Tango Therapeutics and Seneca Therapeutics.

When was Stingray Therapeutics founded?

Stingray Therapeutics was founded in 2018.

Where is Stingray Therapeutics' headquarters located?

Stingray Therapeutics' headquarters is located in Houston, TX, US.

When was Stingray Therapeutics' last funding round?

Stingray Therapeutics' most recent funding round was for $6.6M (USD) in March 2023.

How much has Stingray Therapeutics raised to-date?

As of Mar 31, 2023, Stingray Therapeutics has raised a total of $6.6M (USD).

How many employees does Stingray Therapeutics have?

Stingray Therapeutics has 6 employees as of Feb 5, 2024.

Stingray Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified